{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:44:53Z","timestamp":1794185093127,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>With the broad spread of the chikungunya virus (CHIKV), there is an increasing demand for more effective and broadly protective vaccines. Here, we designed CHIKV mRNA vaccines containing full-length structural proteins or part of structural proteins (envelope proteins) based on conserved sequences from 769 viral strains encompassing four lineages. The vaccine induced strong cellular and humoral immune responses in BALB\/c mice and provided robust protection. Immunization of BALB\/c mice with either of the two vaccines induced high levels of neutralizing antibodies against pseudoviruses from four distinct lineages, highlighting their potential for broad cross-lineage protective efficacy. Immunoglobulin repertoire analysis revealed two important BCR V-J gene combinations, IgHV1-4-IgHJ3 and IgHV1-4-IgHJ2, and lineage-specific immunity analysis revealed significant upregulation of TCRs containing V19 and V20. BCR and TCR immunodiversity may be a potential reason for the broad-spectrum protection against CHIKV afforded by the vaccine. In A129 mice, it elicited lower levels of neutralizing antibodies but prevented mouse mortality and cleared chronic infection. In the rhesus macaque model, both vaccines elicited a certain level of humoral and cellular immune responses and protected the rhesus macaques from the CHIKV challenge. In conclusion, the results from both mouse and rhesus macaque models indicate that the vaccine could be a candidate for clinical use against CHIKV.<\/jats:p>","DOI":"10.1038\/s41392-025-02182-2","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:42:38Z","timestamp":1743151358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["CHIKV mRNA vaccines encoding conserved structural\/envelope proteins confer broad cross-lineage protection against infection"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3438-0027","authenticated-orcid":false,"given":"Xiaoming","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-3827","authenticated-orcid":false,"given":"Qiangming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-9735","authenticated-orcid":false,"given":"Shuaiyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"2182_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/microorganisms7050133","volume":"7","author":"LI Levi","year":"2019","unstructured":"Levi, L. I. & Vignuzzi, M. Arthritogenic alphaviruses: a worldwide emerging threat? Microorganisms 7, 133 (2019).","journal-title":"Microorganisms"},{"key":"2182_CR2","doi-asserted-by":"publisher","first-page":"30234","DOI":"10.2807\/1560-7917.ES.2016.21.20.30234","volume":"21","author":"EO Nsoesie","year":"2016","unstructured":"Nsoesie, E. O. et al. Global distribution and environmental suitability for chikungunya virus, 1952 to 2015. Eurosurveillance 21, 30234 (2016).","journal-title":"Eurosurveillance"},{"key":"2182_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","volume":"15","author":"A Suhrbier","year":"2019","unstructured":"Suhrbier, A. Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nat. Rev. Rheumatol. 15, 597\u2013611 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2182_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00843-x","volume":"9","author":"C Chuong","year":"2024","unstructured":"Chuong, C. et al. Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines. npj Vaccines 9, 59 (2024).","journal-title":"npj Vaccines"},{"key":"2182_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","volume":"9","author":"K Bartholomeeusen","year":"2023","unstructured":"Bartholomeeusen, K. et al. Chikungunya fever. Nat. Rev. Dis. Primers. 9, 17 (2023).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"2182_CR6","doi-asserted-by":"publisher","first-page":"146128","DOI":"10.1016\/j.scitotenv.2021.146128","volume":"778","author":"IM Kramer","year":"2021","unstructured":"Kramer, I. M. et al. The ecophysiological plasticity of Aedes aegypti and Aedes albopictus concerning overwintering in cooler ecoregions is driven by local climate and acclimation capacity. Sci. Total Environ. 778, 146128 (2021).","journal-title":"Sci. Total Environ."},{"key":"2182_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03566-3","volume":"7","author":"NB Tjaden","year":"2017","unstructured":"Tjaden, N. B. et al. Modelling the effects of global climate change on Chikungunya transmission in the 21st century. Sci. Rep. 7, 3813 (2017).","journal-title":"Sci. Rep."},{"key":"2182_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4269\/ajtmh.22-0339","volume":"107","author":"P Srikirin","year":"2022","unstructured":"Srikirin, P. et al. Prevalence, risk factors, and prognosis of liver involvement in adult patients with chikungunya in Thailand. Am. J. Trop. Med. Hyg. 107, 1107 (2022).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2182_CR9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40620-022-01256-6","volume":"35","author":"DM Do Nascimento Costa","year":"2022","unstructured":"Do Nascimento Costa, D. M. et al. Chikungunya virus as a trigger for different renal disorders: an exploratory study. J. Nephrol. 35, 1437\u20131447 (2022).","journal-title":"J. Nephrol."},{"key":"2182_CR10","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.2147\/DDDT.S366112","volume":"16","author":"C Schmidt","year":"2022","unstructured":"Schmidt, C. & Schnierle, B. S. Chikungunya vaccine candidates: current landscape and future prospects. Drug. Des. Dev. Ther. 16, 3663\u20133673 (2022).","journal-title":"Drug. Des. Dev. Ther."},{"key":"2182_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jcv.2009.11.014","volume":"47","author":"S Larrieu","year":"2010","unstructured":"Larrieu, S. et al. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J. Clin. Virol. 47, 85\u201388 (2010).","journal-title":"J. Clin. Virol."},{"key":"2182_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1086\/590003","volume":"47","author":"G Borgherini","year":"2008","unstructured":"Borgherini, G. et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island. Clin. Infect. Dis. 47, 469\u2013475 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"2182_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000389","volume":"3","author":"D Sissoko","year":"2009","unstructured":"Sissoko, D. et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3, e389 (2009).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2182_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007800","volume":"4","author":"M-K Soumahoro","year":"2009","unstructured":"Soumahoro, M.-K. et al. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS ONE 4, e7800 (2009).","journal-title":"PLoS ONE"},{"key":"2182_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001197","volume":"5","author":"M-K Soumahoro","year":"2011","unstructured":"Soumahoro, M.-K. et al. The Chikungunya epidemic on La Reunion Island in 2005\u20132006: a cost-of-illness study. PLoS Negl. Trop. Dis. 5, e1197 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2182_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.vhri.2018.01.004","volume":"17","author":"NJ Alvis-Zakzuk","year":"2018","unstructured":"Alvis-Zakzuk, N. J. et al. Economic costs of chikungunya virus in Colombia. Value Health Reg. Issues 17, 32\u201337 (2018).","journal-title":"Value Health Reg. Issues"},{"key":"2182_CR17","first-page":"301","volume":"8","author":"LB Costa","year":"2023","unstructured":"Costa, L. B. et al. Epidemiology and economic burden of chikungunya: a systematic literature review. J. Travel. Med. 8, 301 (2023).","journal-title":"J. Travel. Med."},{"key":"2182_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.trstmh.2009.07.031","volume":"104","author":"S Rajapakse","year":"2010","unstructured":"Rajapakse, S., Rodrigo, C. & Rajapakse, A. Atypical manifestations of chikungunya infection. Trans. R. Soc. Trop. Med. Hyg. 104, 89\u201396 (2010).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2182_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/v14050969","volume":"14","author":"TYV De Lima Cavalcanti","year":"2022","unstructured":"De Lima Cavalcanti, T. Y. V., Pereira, M. R., de Paula, S. O. & Franca, R. F. D. O. A review on chikungunya virus epidemiology, pathogenesis and current vaccine development. Viruses 14, 969 (2022).","journal-title":"Viruses"},{"key":"2182_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/microorganisms10020354","volume":"10","author":"J Phadungsombat","year":"2022","unstructured":"Phadungsombat, J. et al. Spread of a novel Indian Ocean Lineage carrying E1-K211e\/E2-V264A of chikungunya virus east\/central\/South African genotype across the Indian subcontinent, Southeast Asia, and eastern Africa. Microorganisms 10, 354 (2022).","journal-title":"Microorganisms"},{"key":"2182_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.meegid.2016.04.006","volume":"41","author":"AL Presti","year":"2016","unstructured":"Presti, A. L., Cella, E., Angeletti, S. & Ciccozzi, M. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: an updating review. Infect. Genet. Evol. 41, 270\u2013278 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"2182_CR22","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2019.04.008","volume":"177","author":"H Song","year":"2019","unstructured":"Song, H. et al. Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to chikungunya virus envelope protein. Cell 177, 1714\u20131724e1712 (2019).","journal-title":"Cell"},{"key":"2182_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature09546","volume":"468","author":"L Li","year":"2010","unstructured":"Li, L., Jose, J., Xiang, Y., Kuhn, R. J. & Rossmann, M. G. Structural changes of envelope proteins during alphavirus fusion. Nature 468, 705\u2013708 (2010).","journal-title":"Nature"},{"key":"2182_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004960","volume":"10","author":"C-L Chua","year":"2016","unstructured":"Chua, C.-L., Sam, I.-C., Merits, A. & Chan, Y.-F. Antigenic variation of East\/Central\/South African and Asian chikungunya virus genotypes in neutralization by immune sera. PLoS Negl. Trop. Dis. 10, e0004960 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2182_CR25","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1016\/j.cell.2021.07.033","volume":"184","author":"LE Williamson","year":"2021","unstructured":"Williamson, L. E. et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell 184, 4430\u20134446e4422 (2021).","journal-title":"Cell"},{"key":"2182_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41579-022-00825-7","volume":"21","author":"AS Kim","year":"2023","unstructured":"Kim, A. S. & Diamond, M. S. A molecular understanding of alphavirus entry and antibody protection. Nat. Rev. Microbiol. 21, 396\u2013407 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2182_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1017\/S0950268807008424","volume":"136","author":"F Staikowsky","year":"2008","unstructured":"Staikowsky, F. et al. Retrospective survey of Chikungunya disease in Reunion Island hospital staff. Epidemiol. Infect. 136, 196\u2013206 (2008).","journal-title":"Epidemiol. Infect."},{"key":"2182_CR28","doi-asserted-by":"crossref","unstructured":"Ly, H. Vol. 15 2301573 (Taylor & Francis, 2024).","DOI":"10.1080\/21505594.2024.2375551"},{"key":"2182_CR29","doi-asserted-by":"publisher","first-page":"taad156","DOI":"10.1093\/jtm\/taad156","volume":"31","author":"R McMahon","year":"2024","unstructured":"McMahon, R. et al. A randomized, double-blinded phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults. J. Travel. Med. 31, taad156 (2024).","journal-title":"J. Travel. Med."},{"key":"2182_CR30","doi-asserted-by":"publisher","first-page":"15231","DOI":"10.1021\/acsnano.2c12584","volume":"17","author":"Z Ye","year":"2023","unstructured":"Ye, Z. et al. The mRNA Vaccine Revolution: COVID-19 has launched the future of vaccinology. ACS Nano 17, 15231\u201315253 (2023).","journal-title":"ACS Nano"},{"key":"2182_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2182_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","volume":"8","author":"G Zhang","year":"2023","unstructured":"Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal. Transduct. Target. Ther. 8, 365 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2182_CR33","doi-asserted-by":"publisher","first-page":"e28572","DOI":"10.1002\/jmv.28572","volume":"95","author":"P Rzymski","year":"2023","unstructured":"Rzymski, P., Szuster\u2010Ciesielska, A., Dzieci\u0105tkowski, T., Gwenzi, W. & Fal, A. mRNA vaccines: the future of prevention of viral infections? J. Med. Virol. 95, e28572 (2023).","journal-title":"J. Med. Virol."},{"key":"2182_CR34","first-page":"1","volume":"41","author":"P Roongaraya","year":"2023","unstructured":"Roongaraya, P. & Boonyasuppayakorn, S. Chikungunya vaccines: an update in 2023. Asian Pac. J. Allergy Immunol. 41, 1\u201311 (2023).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"2182_CR35","doi-asserted-by":"publisher","first-page":"e71047","DOI":"10.1371\/journal.pone.0071047","volume":"8","author":"FE Scholte","year":"2013","unstructured":"Scholte, F. E. et al. Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS ONE 8, e71047 (2013).","journal-title":"PLoS ONE"},{"key":"2182_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"2182_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0065-2776(08)01006-7","volume":"101","author":"K Takatsu","year":"2009","unstructured":"Takatsu, K., Kouro, T. & Nagai, Y. Interleukin 5 in the link between the innate and acquired immune response. Adv. Immunol. 101, 191\u2013236 (2009).","journal-title":"Adv. Immunol."},{"key":"2182_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.007","volume":"74","author":"MI Vazquez","year":"2015","unstructured":"Vazquez, M. I., Catalan-Dibene, J. & Zlotnik, A. B cells responses and cytokine production are regulated by their immune microenvironment. Cytokine 74, 318\u2013326 (2015).","journal-title":"Cytokine"},{"key":"2182_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/infdis\/jis033","volume":"205","author":"Y-W Kam","year":"2012","unstructured":"Kam, Y.-W. et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with Chikungunya virus clearance and long-term clinical protection. J. Infect. Dis. 205, 1147\u20131154 (2012).","journal-title":"J. Infect. Dis."},{"key":"2182_CR40","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.02603-09","volume":"84","author":"J Gardner","year":"2010","unstructured":"Gardner, J. et al. Chikungunya virus arthritis in adult wild-type mice. J. Virol. 84, 8021\u20138032 (2010).","journal-title":"J. Virol."},{"key":"2182_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41577-024-01016-6","volume":"24","author":"DJ Rawle","year":"2024","unstructured":"Rawle, D. J., Hugo, L. E., Cox, A. L., Devine, G. J. & Suhrbier, A. Generating prophylactic immunity against arboviruses in vertebrates and invertebrates. Nat. Rev. Immunol. 24, 621\u2013636 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2182_CR42","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1128\/JVI.01926-14","volume":"88","author":"D Halleng\u00e4rd","year":"2014","unstructured":"Halleng\u00e4rd, D. et al. Prime-boost immunization strategies against Chikungunya virus. J. Virol. 88, 13333\u201313343 (2014).","journal-title":"J. Virol."},{"key":"2182_CR43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v11040322","volume":"11","author":"C L\u00f3pez-Camacho","year":"2019","unstructured":"L\u00f3pez-Camacho, C. et al. Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against chikungunya virus. Viruses 11, 322 (2019).","journal-title":"Viruses"},{"key":"2182_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24906-y","volume":"12","author":"PM Folegatti","year":"2021","unstructured":"Folegatti, P. M. et al. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial. Nat. Commun. 12, 4636 (2021).","journal-title":"Nat. Commun."},{"key":"2182_CR45","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JVI.03453-13","volume":"88","author":"D Halleng\u00e4rd","year":"2014","unstructured":"Halleng\u00e4rd, D. et al. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice. J. Virol 88, 2858\u20132866 (2014).","journal-title":"J. Virol"},{"key":"2182_CR46","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/infdis\/jiu014","volume":"209","author":"CJ Roy","year":"2014","unstructured":"Roy, C. J. et al. Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J. Infect. Dis. 209, 1891\u20131899 (2014).","journal-title":"J. Infect. Dis."},{"key":"2182_CR47","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","volume":"27","author":"A August","year":"2021","unstructured":"August, A. et al. A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat. Med. 27, 2224\u20132233 (2021).","journal-title":"Nat. Med."},{"key":"2182_CR48","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/j.vaccine.2011.01.076","volume":"29","author":"CD Partidos","year":"2011","unstructured":"Partidos, C. D. et al. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. Vaccine 29, 3067\u20133073 (2011).","journal-title":"Vaccine"},{"key":"2182_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78009-7","volume":"10","author":"I Szurgot","year":"2020","unstructured":"Szurgot, I., Ljungberg, K., K\u00fcmmerer, B. M. & Liljestr\u00f6m, P. Infectious RNA vaccine protects mice against chikungunya virus infection. Sci. Rep. 10, 21076 (2020).","journal-title":"Sci. Rep."},{"key":"2182_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/600381","volume":"200","author":"T Couderc","year":"2009","unstructured":"Couderc, T. et al. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 200, 516\u2013523 (2009).","journal-title":"J. Infect. Dis."},{"key":"2182_CR51","doi-asserted-by":"publisher","first-page":"eaav5062","DOI":"10.1126\/sciimmunol.aav5062","volume":"4","author":"JM Fox","year":"2019","unstructured":"Fox, J. M. et al. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-Fc\u03b3R interaction on monocytes. Sci. Immunol. 4, eaav5062 (2019).","journal-title":"Sci. Immunol."},{"key":"2182_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003764","volume":"9","author":"I-K Yoon","year":"2015","unstructured":"Yoon, I.-K. et al. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl. Trop. Dis. 9, e0003764 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2182_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00722-x","volume":"8","author":"N Cherian","year":"2023","unstructured":"Cherian, N. et al. Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need. npj Vaccines 8, 123 (2023).","journal-title":"npj Vaccines"},{"key":"2182_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/vim.2012.0061","volume":"26","author":"H Bao","year":"2013","unstructured":"Bao, H. et al. Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA vaccine. Viral Immunol. 26, 75\u201383 (2013).","journal-title":"Viral Immunol."},{"key":"2182_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.meegid.2015.01.017","volume":"31","author":"B Pratheek","year":"2015","unstructured":"Pratheek, B., Suryawanshi, A. R., Chattopadhyay, S. & Chattopadhyay, S. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8+ T cell response and advancement of epitope based immunotherapy for CHIKV infection. Infect. Genet. Evol. 31, 118\u2013126 (2015).","journal-title":"Infect. Genet. Evol."},{"key":"2182_CR56","doi-asserted-by":"publisher","first-page":"e83527","DOI":"10.1172\/jci.insight.83527","volume":"2","author":"P Roques","year":"2017","unstructured":"Roques, P. et al. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight 2, e83527 (2017).","journal-title":"JCI Insight"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02182-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02182-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02182-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:42:44Z","timestamp":1743151364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02182-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2182"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02182-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}